These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 25099657)

  • 1. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral delivery of peptide drugs: barriers and developments.
    Hamman JH; Enslin GM; Kotzé AF
    BioDrugs; 2005; 19(3):165-77. PubMed ID: 15984901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging trends in oral delivery of peptide and protein drugs.
    Mahato RI; Narang AS; Thoma L; Miller DD
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):153-214. PubMed ID: 14584523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs.
    Park JW; Kim SJ; Kwag DS; Kim S; Park J; Youn YS; Bae YH; Lee ES
    Curr Pharm Des; 2015; 21(22):3097-110. PubMed ID: 26027575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies and industrial perspectives to improve oral absorption of biological macromolecules.
    Liu C; Kou Y; Zhang X; Cheng H; Chen X; Mao S
    Expert Opin Drug Deliv; 2018 Mar; 15(3):223-233. PubMed ID: 29111841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral peptide delivery: Translational challenges due to physiological effects.
    Tyagi P; Pechenov S; Anand Subramony J
    J Control Release; 2018 Oct; 287():167-176. PubMed ID: 30145135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral colon-specific drug delivery of protein and peptide drugs.
    Sinha V; Singh A; Kumar RV; Singh S; Kumria R; Bhinge J
    Crit Rev Ther Drug Carrier Syst; 2007; 24(1):63-92. PubMed ID: 17430100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials.
    Aguirre TA; Teijeiro-Osorio D; Rosa M; Coulter IS; Alonso MJ; Brayden DJ
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):223-241. PubMed ID: 26921819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches for enhancing oral bioavailability of peptides and proteins.
    Renukuntla J; Vadlapudi AD; Patel A; Boddu SH; Mitra AK
    Int J Pharm; 2013 Apr; 447(1-2):75-93. PubMed ID: 23428883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral biodrug delivery using cell-penetrating peptide.
    Khafagy el-S; Morishita M
    Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral peptide delivery: challenges and the way ahead.
    Dubey SK; Parab S; Dabholkar N; Agrawal M; Singhvi G; Alexander A; Bapat RA; Kesharwani P
    Drug Discov Today; 2021 Apr; 26(4):931-950. PubMed ID: 33444788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral delivery of peptides and proteins using lipid-based drug delivery systems.
    Li P; Nielsen HM; Müllertz A
    Expert Opin Drug Deliv; 2012 Oct; 9(10):1289-304. PubMed ID: 22897647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral drug delivery systems using chemical conjugates or physical complexes.
    Al-Hilal TA; Alam F; Byun Y
    Adv Drug Deliv Rev; 2013 Jun; 65(6):845-64. PubMed ID: 23220326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional matrices for oral peptide delivery.
    Bernkop-Schnürch A; Walker G
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):459-501. PubMed ID: 11763498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
    Yamamoto A
    Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs.
    Yamamoto A; Ukai H; Morishita M; Katsumi H
    Pharmacol Ther; 2020 Jul; 211():107537. PubMed ID: 32201316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery.
    Leonaviciute G; Bernkop-Schnürch A
    Expert Opin Drug Deliv; 2015; 12(11):1703-16. PubMed ID: 26477549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral peptide and protein delivery: intestinal obstacles and commercial prospects.
    Smart AL; Gaisford S; Basit AW
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1323-35. PubMed ID: 24816134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
    Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
    Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
    Yun Y; Cho YW; Park K
    Adv Drug Deliv Rev; 2013 Jun; 65(6):822-32. PubMed ID: 23123292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.